Dr. Ilyas Singeç is the Director of the Stem Cell Translation Laboratory (SCTL) at the National Center for Advancing Translational Sciences. He is interested in industrial-scale cellular engineering for regenerative medicine, characterization of cell identities and developmental states, and disease modeling of neurological and psychiatric disorders. Scientists at the SCTL are working on various projects to address efficiency, reproducibility, scalability, and other roadblocks in the translation of iPSCs into therapies.

Listen to the episode here.